دورية أكاديمية
Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization.
العنوان: | Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization. |
---|---|
المؤلفون: | Ramdhani, K., Beijer-Verduin, J., Ebbers, S. C., van Rooij, R., Smits, M. L. J., Bruijnen, R. C. G., de Jong, H. W. A. M., Lam, M. G. E. H., Braat, A. J. A. T. |
المصدر: | European Journal of Nuclear Medicine & Molecular Imaging; Jun2024, Vol. 51 Issue 7, p2114-2123, 10p |
مصطلحات موضوعية: | DOSE-response relationship (Radiation), NEUROENDOCRINE tumors, PROGRESSION-free survival, MAGNETIC resonance imaging, OVERALL survival, ABSORBED dose, LIVER |
مستخلص: | Purpose: Aim of this study was to investigate a dose-response relationship, dose-toxicity relationship, progression free survival (PFS) and overall survival (OS) in neuroendocrine tumour liver metastases (NELM) treated with holmium-166-microspheres radioembolization ([166Ho]-radioembolization). Materials and methods: Single center, retrospective study included patients with NELM that received [166Ho]-radioembolization with post-treatment SPECT/CT and CECT or MRI imaging for 3 months follow-up. Post-treatment SPECT/CT was used to calculate tumour (D |
Copyright of European Journal of Nuclear Medicine & Molecular Imaging is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
قاعدة البيانات: | Complementary Index |
كن أول من يترك تعليقا!